{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:52:30Z","timestamp":1778935950288,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:00:00Z","timestamp":1556323200000},"content-version":"vor","delay-in-days":2307,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1186\/1939-4551-6-15","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T12:55:57Z","timestamp":1378904157000},"page":"15","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days"],"prefix":"10.1016","volume":"6","author":[{"given":"Karin D","family":"Petersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kronborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen N","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorte","family":"Gyrd-Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1186\/1939-4551-6-15_bib0005","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.04.00013904","article-title":"Prevalence and rate of diagnosis of allergic rhinitis in Europe","volume":"24","author":"Bauchau","year":"2004","journal-title":"EurRespir J"},{"key":"10.1186\/1939-4551-6-15_bib0010","series-title":"White Book on Allergy","author":"Pawankar","year":"2011"},{"key":"10.1186\/1939-4551-6-15_bib0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.rmed.2003.11.015","article-title":"National prevalence of respiratory allergic disorders","volume":"98","author":"Dahl","year":"2004","journal-title":"Respir Med"},{"key":"10.1186\/1939-4551-6-15_bib0020","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaci.2005.05.009","article-title":"Change in prevalence of IgE sensitization and mean total IgE with age and cohort","volume":"116","author":"Jarvis","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1186\/1939-4551-6-15_bib0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-7022-2-20","article-title":"A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy","volume":"2","author":"Calderon","year":"2012","journal-title":"Clin Transl Allergy"},{"key":"10.1186\/1939-4551-6-15_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mai.2001.112027","article-title":"Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial","volume":"107","author":"Walker","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1186\/1939-4551-6-15_bib0035","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1046\/j.1365-2222.2001.01027.x","article-title":"Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study","volume":"31","author":"Purello-D'Ambrosio","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1186\/1939-4551-6-15_bib0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1186\/1939-4551-6-15_bib0045","first-page":"373","article-title":"The cost of productivity losses associated with allergic rhinitis","volume":"6","author":"Crystal-Peters","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1186\/1939-4551-6-15_bib0050","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1185\/030079906X112552","article-title":"Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective","volume":"22","author":"Lamb","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1186\/1939-4551-6-15_bib0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0301-0546(05)73246-8","article-title":"Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy","volume":"33","author":"Petersen","year":"2005","journal-title":"Allergol Immunopathol (Madr.)"},{"key":"10.1186\/1939-4551-6-15_bib0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1398-9995.2009.02269.x","article-title":"Allergic rhinitis and the common cold - high cost to society","volume":"65","author":"Hellgren","year":"2010","journal-title":"Allergy"},{"key":"10.1186\/1939-4551-6-15_bib0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1183\/09031936.95.08060885","article-title":"Quality of life measurement in asthma","volume":"8","author":"Jones","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1186\/1939-4551-6-15_bib0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bmj.316.7130.542","article-title":"What are quality of life measurements measuring?","volume":"316","author":"Muldoon","year":"1998","journal-title":"BMJ"},{"key":"10.1186\/1939-4551-6-15_bib0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0091-6749(99)70380-5","article-title":"Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire","volume":"104","author":"Juniper","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1186\/1939-4551-6-15_bib0080","series-title":"The measurement and evaluation of health status using EQ-5D: A European perspective (Evidence from the EuroQol BIOMED research programme)","author":"Brooks","year":"2003"},{"key":"10.1186\/1939-4551-6-15_bib0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/07853890109002086","article-title":"The 15D instrument of health-related quality of life: properties and applications","volume":"33","author":"Sintonen","year":"2001","journal-title":"Ann Med"},{"key":"10.1186\/1939-4551-6-15_bib0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1398-9995.2007.01583.x","article-title":"Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires","volume":"63","author":"Petersen","year":"2008","journal-title":"Allergy"},{"key":"10.1186\/1939-4551-6-15_bib0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurpub\/ckq063","article-title":"Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?","volume":"21","author":"Petersen","year":"2010","journal-title":"Eur J Public Health"},{"key":"10.1186\/1939-4551-6-15_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S026646230999081X","article-title":"Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy","volume":"26","author":"Petersen","year":"2010","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1186\/1939-4551-6-15_bib0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000071546","article-title":"The WHO ARIA (allergic rhinitis and its impact on asthma) initiative","volume":"82","author":"Bachert","year":"2003","journal-title":"Chem Immunol Allergy"},{"key":"10.1186\/1939-4551-6-15_bib0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1398-9995.2006.01305.x","article-title":"GINA guidelines on asthma and beyond","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"key":"10.1186\/1939-4551-6-15_bib0115","series-title":"Measurement and Valuation of Health-related Quality of Life","author":"Wittrup-Jensen","year":"2006"},{"key":"10.1186\/1939-4551-6-15_bib0120","series-title":"The 15D-measure of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system","author":"Sintonen","year":"1994"},{"key":"10.1186\/1939-4551-6-15_bib0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1403494809105287","article-title":"Generation of a Danish TTO value set for EQ-5D health states","volume":"37","author":"Wittrup-Jensen","year":"2009","journal-title":"Scand J Public Health"},{"key":"10.1186\/1939-4551-6-15_bib0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1186\/1939-4551-6-15_bib0135","series-title":"Medical Statistics","author":"Kirkwood","year":"2003"},{"issue":"3","key":"10.1186\/1939-4551-6-15_bib0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10198-012-0402-y","article-title":"Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients","volume":"14","author":"Lunde","year":"2013","journal-title":"Eur J Health Econ"},{"key":"10.1186\/1939-4551-6-15_bib0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11136-008-9317-6","article-title":"Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders","volume":"17","author":"Moock","year":"2008","journal-title":"Qual Life Res"},{"key":"10.1186\/1939-4551-6-15_bib0150","first-page":"17","article-title":"Impact of allergy and asthma on quality of life and comparison with other diseases","volume":"44","author":"Petersen","year":"2008","journal-title":"Drugs Today (Barc.)"},{"key":"10.1186\/1939-4551-6-15_bib0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1157\/13080929","article-title":"Clinical and patient based evaluation of immunotherapy for grass pollen and mite allergy","volume":"33","author":"Dam Petersen","year":"2005","journal-title":"Allergol Immunopathol (Madr.)"},{"key":"10.1186\/1939-4551-6-15_bib0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1186\/1939-4551-6-15_bib0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1034\/j.1398-9995.2001.00834.x","article-title":"Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity","volume":"56","author":"Pichler","year":"2001","journal-title":"Allergy"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1939-4551-6-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1939-4551-6-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119306374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119306374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1939-4551-6-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T13:53:03Z","timestamp":1688478783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119306374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":33,"alternative-id":["S1939455119306374"],"URL":"https:\/\/doi.org\/10.1186\/1939-4551-6-15","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"article-number":"15"}}